Angio Suites Market - Forecast(2024 - 2030)

Angio Suites Market Overview

Angio Suites Market size is estimated to reach $3.2 billion by 2027, growing at a CAGR of 8.8% during the forecast period 2022-2027. Angio suites can be delineated as well-sourced polyvalent spaces used to execute interventional vascular measures. Several medical procedures such as minimally invasive endovascular surgery, ischemic stroke treatment, myelograms, aortic dissection treatment, ruptured aneurysm treatment, diagnostic imaging procedures, and medical imaging practices are performed in these facilities. The versatility of Angio suites is a blessing indeed as these facilities are capable of executing tons of medical procedures. Angio suites confer a one-stop solution to patients which makes the overall procedure less traumatic as patients are not required to move in between different operating rooms. The Majority of procedures executed in agio suites are centered around minimally invasive technology that eventually condenses the overall hospital stays. The Angio suites market outlook is extremely captivating as millions of people every year fall victim to life-threatening health complications. Nevertheless, proliferating old-age population, accruing cognizance regarding early diagnosis, the rising pervasiveness of cardiovascular hitches, and honest efforts of researchers in quest of developing effective cures are the factors set to drive the growth of the Angio Suites Market for the period 2022-2027.

Report Coverage

The report: “Angio Suites Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Angio Suites Market. 

By Type: Single plane and Biplane. 
By Equipment: C-arm, X-ray detector and generator, and others. 
By Application: Ruptured aneurysms treatment, Arterial venous malformations surgery, Intravenous tissue plasminogen activator (Ischemic strokes treatment), Coronary angiograms, Intravascular therapy, Myelograms, vertebroplasty, Angioplasty, and others. 
By End User: Hospitals, Cardiovascular catheterization laboratories, Diagnostic facilities, and others. 
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa)

Key Takeaways

• Geographically, the North America Angio Suites Market accounted for the highest revenue share in 2021. However, Asia-Pacific is poised to dominate the market over the period 2022-2027.
• The broadening demand for Angio suites in the treatment of a variety of illnesses, augmentation inattentiveness of people regarding health complications, and technological breakthroughs transfiguring the medical procedures are said to be preeminent drivers driving the growth of the Angio Suites Market. Exorbitant hard-cash requirements during setup, rudimentary healthcare setup in low and middle-income countries, and scarcity of top-flight professionals are said to reduce the market growth. 
• Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Angio Suites Market report.

Angio Suites Market Segment Analysis-By Application 

The Angio Suites Market based on the application type can be further segmented into ruptured aneurysms treatment, arterial-venous malformations surgery, intravenous tissue plasminogen activator (Ischemic strokes treatment), coronary angiograms (angiography), intravascular therapy, myelograms, vertebroplasty, angioplasty, and others. The angiography and angioplasty segment held the largest share in 2021. The growth is owing to widescale usage in the diagnosis and treatment of congested blood vessels. Atherosclerosis is one of the most common blood complications that has come to the foreground in recent years. Due to widescale obesity, diabetes, and smoking the problem of cholesterol and blood pressure tipping off the scale has become a part of modern-day society. High cholesterol and fats get congested in the blood vessel in the form of plaque and subject them to turn narrow. Such problems are effectively diagnosed and treated with the help of angiography and angioplasty. Nevertheless, angioplasty and angiography segments are estimated to be the fastest-growing with a CAGR of 9.7% over the forecast period 2022-2027. This growth is owing to the effectiveness of such procedures which is drawing the attention of many people toward it. Angiography with its precise diagnosis and angioplasty with its minimally invasive nature can change the overall experience of patients during procedures and can reduce in-hospital stay. 

Angio Suites Market Segment Analysis-By End User 

The Angio Suites Market based on end-user can be further segmented into hospitals, cardiovascular catheterization laboratories, diagnostic facilities, and others. The catheterization laboratories (CATH) segment held the largest share in 2021. The growth is owing to its well-equipped nature as unlike hospitals it is the core business of such facilities. Moreover, cardiac catheterization, a procedure offered by Cath labs helps in mitigating any abnormality inflicted with blood vessels without making incisions which caught the attention of patients many times. Moreover, the hospital segment is estimated to be the fastest-growing segment with a CAGR of 9.4% over the forecast period 2022-2027. This growth is owing to a growing demand for outpatient surgeries. Also, with increasing government healthcare spending the overall infrastructure and expertise of hospitals are bettering day after day is helping in the growth of the market. Moreover, hospitals have started developing specialized areas under the name of CATH labs to execute various angiographic and Angio plastic procedures and this step will help them in capturing a bigger chunk of the market as hospitals are the first point of contact for people. 

Angio Suite Market Segment Analysis-By Geography 

The Angio Suites Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 39% of the overall market in 2021. The growth in this segment is owing to the factors such as the widescale presence of top-flight healthcare facilities like hospitals and laboratories. Moreover, full-fledged economies make it easy for the government to allocate necessary packages in order to build new facilities or maintain the infrastructure of existing ones. Moreover, the high attentiveness of people toward healing complications and the existence of adequate treatments is driving the growth of the Angio suite market in the segment. However, Asia-Pacific is expected to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to upgrading healthcare infrastructure with the budding economic affluence of nations like China and India. On another hand, the tremendous pace at which the population of Japan and China is turning old is playing an essential contribution to the intensification of heart-associated complications.

Angio Suites Market Drivers

Escalating atherosclerosis is Anticipated to Boost Market Demand

According to International Diabetes Federation (IDF) report, there were more than 535 million people inflicted with diabetes in the year 2021 and the figure is likely to jump up to 780-783 million by the year 2045. Moreover, rising incidences of obesity due to poor ingestion and sedentary habits are likely to add fuel to the fire and are anticipated to worsen the situation beyond a reasonable degree. As a result, the atherosclerosis complication is afflicting millions of people every year and resulting in heart attacks and claiming millions of lives. This factor is anticipated to be the biggest driver of the growth of the market. 

Rising government spending is Expected to Boost Market Demand

As a major faction of the world population is turning the hospital and other medical facilities have been overwhelmed by the surge in the trend of hospitalization. According to WHO, 600-700 million, the figure representing the size current of the old-age population will reach more than 2 billion geriatrics in foreseeable future. In response governments all over the globe have started taking necessary measures to meet the need of the hour which is “Full-Fledge Healthcare Infrastructure.” As a result, governments have heightened the overall flow of hard cash which is likely to support the Angio suites market. 

Angio Suites Market Challenges

Rudimentary infrastructure in middle-income countries, extortionate fund requirements, and scarcity of top-flight professionals are Anticipated to Hamper Market Growth

Except for India and China, various low- and middle-income countries in Africa and Asia do not have the necessary healthcare infrastructure that they need to ensure proper treatment of the massive population that they hold. Besides, the Initial setup of Angio suites requires paying a bit over the odds which may turn interested individuals aversive toward it, and eventually, they might call off their plans. On another hand, the scarcity of top-of-the-line professionals with adequate skill sets may hamper the growth of the market. WHO estimates a projected shortfall of 18 million health workers by 2030, mostly in low- and lower-middle-income countries. The chronic under-investment in education and training of health workers in some countries and the mismatch between education and employment strategies in relation to health systems and population needs are contributing to continuous shortages. 

Angio Suites Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Angio Suites Market. Key companies in this market are- 

1. 3D systems
2. Canon Medical Systems
3. GE Healthcare
4. Siemens Healthcare
5. Philips Healthcare
6. Lam Vascular
7. Hitachi Healthcare
8. ESAOTE
9. IMRIS
10. Carestream Health

Recent Developments

• On December 21, 2021, GE Healthcare, an auxiliary company of well-known Massachusetts, United states-based company “General Electric” announced the successful acquisition of Boston, United States-based imaging company “BK Medical.” GE has made a payment of $1.45 billion in order to bring the acquisition to a close. Moreover, the transaction has strengthened the ultrasound business of GE Healthcare. 
• On July 15, 2021, Fujifilm Healthcare, a subsidiary of Tokyo, Japan-based conglomerate “Fujifilm” announced the successful acquisition of the business of diagnostic imaging from Hitachi company. Fujifilm has made a payment of 1.3 billion euros in order to wrap up the acquisition which strengthens its position in diagnostics on the global stage. 
• On January 20, 2021, Amsterdam, Netherlands-based healthcare company “Philips Healthcare” which deals in medical imaging systems announced that the company has reached an acquisition agreement with Massachusetts, United States-based medical devices integration providing company “Capsule technologies.” A payment of $635 million has been made by Philips to conclude the process.

Relevant Reports:

Ischemic Cardiomyopathy Market – Forecast (2022 - 2027)

Report Code: HCR 0333

Ischemic Stroke Diagnostic Equipment Market – Forecast (2022 - 2027)

Report Code: HCR 1269

Home Healthcare Market - Forecast(2022 - 2027)

Report Code: HCR 0004 

For more Lifesciences and Healthcare Market reports, please click here